Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer.
Affiliation
Mount Vernon Cancer Centre, Northwood, UK.Issue Date
2014-05
Metadata
Show full item recordAbstract
This study is an analysis of the pre-trial quality assurance (QA) exercises submitted by clinicians from radiotherapy (RT) centres across Europe and Canada to qualify for participation in the CONVERT trial.Citation
Is pre-trial quality assurance necessary? Experiences of the CONVERT Phase III randomized trial for good performance status patients with limited-stage small-cell lung cancer. 2014, 87 (1037):20130653 Br J RadiolJournal
The British Journal of RadiologyDOI
10.1259/bjr.20130653PubMed ID
24620839Type
ArticleLanguage
enISSN
1748-880Xae974a485f413a2113503eed53cd6c53
10.1259/bjr.20130653
Scopus Count
Collections
Related articles
- Quality assurance of the SCOPE 1 trial in oesophageal radiotherapy.
- Authors: Wills L, Maggs R, Lewis G, Jones G, Nixon L, Staffurth J, Crosby T, SCOPE 1 trial management group and collaborators.
- Issue date: 2017 Nov 15
- Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.
- Authors: Clark CH, Miles EA, Urbano MT, Bhide SA, Bidmead AM, Harrington KJ, Nutting CM, UK PARSPORT Trial Management Group collaborators.
- Issue date: 2009 Jul
- Effect of accurate heart delineation on cardiac dose during the CONVERT trial.
- Authors: Groom N, Wilson E, Faivre-Finn C
- Issue date: 2017 May
- Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202.
- Authors: Sanuki-Fujimoto N, Ishikura S, Hayakawa K, Kubota K, Nishiwaki Y, Tamura T
- Issue date: 2009 Jun 2
- The TRENDY multi-center randomized trial on hepatocellular carcinoma - Trial QA including automated treatment planning and benchmark-case results.
- Authors: Habraken SJM, Sharfo AWM, Buijsen J, Verbakel WFAR, Haasbeek CJA, Öllers MC, Westerveld H, van Wieringen N, Reerink O, Seravalli E, Braam PM, Wendling M, Lacornerie T, Mirabel X, Weytjens R, Depuydt L, Tanadini-Lang S, Riesterer O, Haustermans K, Depuydt T, Dwarkasing RS, Willemssen FEJA, Heijmen BJM, Méndez Romero A
- Issue date: 2017 Dec